These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 26797499

  • 1. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS, Kadzirange G, Bandason T, Chipiti MM, Gwambiwa B, Makoga F, Chungu P, Kaguru P, Dheda K.
    BMC Infect Dis; 2016 Jan 22; 16():20. PubMed ID: 26797499
    [Abstract] [Full Text] [Related]

  • 2. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J, Theron G, Chanda D, Clowes P, Rachow A, Lesosky M, Hoelscher M, Mwaba P, Pym A, Dheda K, TB-NEAT team.
    BMC Infect Dis; 2015 Jul 09; 15():262. PubMed ID: 26156025
    [Abstract] [Full Text] [Related]

  • 3. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR.
    Cochrane Database Syst Rev; 2016 May 10; 2016(5):CD011420. PubMed ID: 27163343
    [Abstract] [Full Text] [Related]

  • 4. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.
    BMC Infect Dis; 2015 Feb 15; 15():62. PubMed ID: 25888317
    [Abstract] [Full Text] [Related]

  • 5. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.
    PLoS One; 2015 Feb 15; 10(7):e0133756. PubMed ID: 26222142
    [Abstract] [Full Text] [Related]

  • 6. Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
    Sabur NF, Esmail A, Brar MS, Dheda K.
    BMC Infect Dis; 2017 Dec 28; 17(1):803. PubMed ID: 29282005
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD, Kerkhoff AD, Vogt M, Wood R.
    Lancet Infect Dis; 2012 Mar 28; 12(3):201-9. PubMed ID: 22015305
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
    Peter JG, Theron G, Muchinga TE, Govender U, Dheda K.
    PLoS One; 2012 Mar 28; 7(7):e39966. PubMed ID: 22815718
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, Freedberg KA, Bassett IV.
    BMC Infect Dis; 2014 Feb 26; 14():110. PubMed ID: 24571362
    [Abstract] [Full Text] [Related]

  • 10. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
    Gina P, Randall PJ, Muchinga TE, Pooran A, Meldau R, Peter JG, Dheda K.
    BMC Infect Dis; 2017 May 12; 17(1):339. PubMed ID: 28499418
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
    Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA.
    J Acquir Immune Defic Syndr; 2009 Oct 01; 52(2):145-51. PubMed ID: 19692904
    [Abstract] [Full Text] [Related]

  • 12. Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial.
    Naidoo P, Esmail A, Peter JG, Davids M, Fadul M, Dheda K.
    Int J Infect Dis; 2019 Feb 01; 79():37-43. PubMed ID: 30292891
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD, Kerkhoff AD, Vogt M, Wood R.
    AIDS; 2012 Aug 24; 26(13):1635-43. PubMed ID: 22555166
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.
    Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K.
    Eur Respir J; 2012 Nov 24; 40(5):1211-20. PubMed ID: 22362849
    [Abstract] [Full Text] [Related]

  • 15. Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?
    Peter JG, Theron G, Dheda K.
    PLoS One; 2013 Nov 24; 8(2):e54875. PubMed ID: 23390504
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study.
    Bjerrum S, Kenu E, Lartey M, Newman MJ, Addo KK, Andersen AB, Johansen IS.
    BMC Infect Dis; 2015 Oct 01; 15():407. PubMed ID: 26427365
    [Abstract] [Full Text] [Related]

  • 17. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
    Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A.
    PLoS One; 2010 Mar 24; 5(3):e9848. PubMed ID: 20352098
    [Abstract] [Full Text] [Related]

  • 18. Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region.
    Drain PK, Gounder L, Sahid F, Moosa MY.
    Sci Rep; 2016 Feb 11; 6():19992. PubMed ID: 26865526
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H, Mathabire Rucker SC, Cossa L, Bastard M, Amoros I, Manhiça I, Mbendera K, Telnov A, Szumilin E, Sanchez-Padilla E, Molfino L.
    PLoS Med; 2019 Apr 11; 16(4):e1002792. PubMed ID: 31039161
    [Abstract] [Full Text] [Related]

  • 20. Urinary lipoarabinomannan in individuals with sputum-negative pulmonary tuberculosis.
    Ajantha P, Puri MM, Tayal D, Khalid U.
    Indian J Med Res; 2024 Feb 01; 159(2):206-212. PubMed ID: 38577859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.